dutasteride and tamsulosin hydrochloride

FDA Drug Profile

dutasteride and tamsulosin hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: capsule.

Drug details

Generic Name
dutasteride and tamsulosin hydrochloride
Sponsor
Catalent Germany Schorndorf GmbH
NDC Codes
1
Dosage Forms
CAPSULE
Active Ingredients
DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE JALYN is a combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. ( 1.1 ) Limitations of Use: Dutasteride-containing products, including JALYN, are not approved for the prevention of prostate cancer. ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (BPH) Treatment JALYN (dutasteride and tamsulosin hydrochloride) capsules are indicated for the treatment of symptomatic BPH in men with an enlarged prostate. 1.2 Limitations of Use Dutasteride-containing products, including JALYN, are not approved for the prevention of prostate cancer.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.